13F HOLDINGS REPORT
Qiming U.S. Ventures Management, LLC
Quarter ended Q1 2023 · Filed January 24, 2023 · Accession 0001104659-23-006182
Total Value
$75.6M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ICOSAVAX INC | 45114M109 | 3,510,228 | $27.9M | 36.87% |
| 2 | VENTYX BIOSCIENCES INC | 92332V107 | 746,370 | $24.5M | 32.37% |
| 3 | HILLEVAX INC | 43157M102 | 558,923 | $9.4M | 12.37% |
| 4 | KEZAR LIFE SCIENCES INC | KZR | 828,711 | $5.8M | 7.72% |
| 5 | TALARIS THERAPEUTICS INC | 87410C104 | 2,932,606 | $3.0M | 3.96% |
| 6 | JASPER THERAPEUTICS INC | JSPRW | 5,852,982 | $2.8M | 3.74% |
| 7 | ELEVATION ONCOLOGY INC | 28623U101 | 2,370,142 | $2.3M | 2.98% |